Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-03
DOI
10.3389/fmed.2021.639804
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
- (2020) David S. Fedson et al. mBio
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
- (2020) Shikha Garg et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Statin therapy in COVID-19 infection
- (2020) Vincenzo Castiglione et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Statins: Could an old friend help in the fight against COVID‐19?
- (2020) Raul R. Rodrigues‐Diez et al. BRITISH JOURNAL OF PHARMACOLOGY
- In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
- (2020) Xiao-Jing Zhang et al. Cell Metabolism
- Teaching Old Drugs New Tricks: Statins for COVID-19?
- (2020) David C. Fajgenbaum et al. Cell Metabolism
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- SARS-CoV-2 and diabetes: New challenges for the disease
- (2020) Cecília Cristelo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
- (2020) Anton De Spiegeleer et al. Journal of the American Medical Directors Association
- Statin therapy in COVID-19 infection: much more than a single pathway
- (2020) Maurizio Bifulco et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm
- (2020) Eddie W. Fakhouri et al. Antioxidants
- Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections
- (2020) Frank A. D. T. G. Wagener et al. Antioxidants
- Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system
- (2020) Maria Grazia Lazzaroni et al. BLOOD REVIEWS
- Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study
- (2020) Bertrand Cariou et al. DIABETES & METABOLISM
- Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications
- (2020) Devendra Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Immune modulatory effects of statins
- (2018) Robert Zeiser IMMUNOLOGY
- Pravastatin improves fetal survival in mice with a partial deficiency of heme oxygenase-1
- (2018) Abraham Tsur et al. PLACENTA
- Heme Oxygenase-1 Expression Affects Murine Abdominal Aortic Aneurysm Progression
- (2016) Junya Azuma et al. PLoS One
- MatchIt: Nonparametric Preprocessing for Parametric Causal Inference
- (2015) Daniel E. Ho et al. Journal of Statistical Software
- Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
- (2014) Xiao Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms of Action and Efficacy of Statins against Influenza
- (2014) Parvaneh Mehrbod et al. Biomed Research International
- Treating influenza with statins and other immunomodulatory agents
- (2013) David S. Fedson ANTIVIRAL RESEARCH
- Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
- (2012) Alexios S. Antonopoulos et al. CURRENT PHARMACEUTICAL DESIGN
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started